(Q33420172)

26 July 2017

title

Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies (English)

1 reference

atypical hemolytic uremic syndrome

26 July 2017

main subject

1 reference

Giuseppe Remuzzi

15

0 references

Petra Muus

3

object named as

Petra Muus

1 reference

26 July 2017

11

Timothy Goodship

1 reference

26 July 2017

Christoph Licht

1

1 reference

26 July 2017

Larry A Greenbaum

2

1 reference

26 July 2017

Sunil Babu

4

1 reference

26 July 2017

Camille L Bedrosian

5

1 reference

26 July 2017

David J Cohen

6

1 reference

26 July 2017

Yahsou Delmas

7

1 reference

26 July 2017

Kenneth Douglas

8

1 reference

26 July 2017

Richard R Furman

9

1 reference

26 July 2017

Osama A Gaber

10

1 reference

26 July 2017

Maria Herthelius

12

1 reference

26 July 2017

Maryvonne Hourmant

13

1 reference

26 July 2017

Christophe M Legendre

14

1 reference

26 July 2017

Neil Sheerin

16

1 reference

26 July 2017

Antonella Trivelli

17

1 reference

26 July 2017

Chantal Loirat

18

1 reference

26 July 2017

language of work or name

English

0 references

publication date

4 February 2015

1 reference

26 July 2017

number of pages

13

1 reference

inferred from page(s)

published in

Kidney International

1 reference

26 July 2017

volume

87

1 reference

26 July 2017

issue

5

1 reference

26 July 2017

page(s)

1061-1073

1 reference

Syndromes of thrombotic microangiopathy

26 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424817

Discontinuation of eculizumab maintenance treatment for atypical hemolytic uremic syndrome: a report of 10 cases

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424817

Phenotypic expansion of DGKE-associated diseases

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424817

Macrovascular involvement in a child with atypical hemolytic uremic syndrome

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424817

Eculizumab: a review of its use in atypical haemolytic uraemic syndrome

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424817

Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424817

Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424817

Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424817

The use of eculizumab in renal transplantation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424817

Peritubular capillary rarefaction: a new therapeutic target in chronic kidney disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424817

Neurologic involvement in atypical hemolytic uremic syndrome and successful treatment with eculizumab.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424817

An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424817

Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424817

Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424817

Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424817

Eculizumab for atypical hemolytic uremic syndrome recurrence in renal transplantation.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424817

Eculizumab therapy in a child with hemolytic uremic syndrome and CFI mutation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424817

Quality of life in patients undergoing hemodialysis or peritoneal dialysis treatment

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424817

Plasmatherapy in atypical hemolytic uremic syndrome

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424817

Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424817

Thrombotic microangiopathies: new insights and new challenges

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424817

Thrombotic microangiopathy: new insights

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424817

Atypical hemolytic-uremic syndrome

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424817

Platelet-associated complement factor H in healthy persons and patients with atypical HUS.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424817

Thrombomodulin mutations in atypical hemolytic-uremic syndrome

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424817

Podocyte repopulation contributes to regression of glomerular injury induced by ACE inhibition

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424817

Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424817

Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424817

FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424817

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424817

EQ-5D: a measure of health status from the EuroQol Group

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424817

Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424817

Relapse of aHUS after discontinuation of therapy with eculizumab in a patient with aHUS and factor H mutation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424817

Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424817

Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424817

ACE inhibition reduces glomerulosclerosis and regenerates glomerular tissue in a model of progressive renal disease

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424817

Safety and long-term efficacy of eculizumab in a renal transplant patient with recurrent atypical hemolytic-uremic syndrome

31 October 2018

1 reference

12 December 2020

Validation of the Center for Medicare and Medicaid Services algorithm for eligibility for dialysis

1 reference

12 December 2020

Successful discontinuation of eculizumab therapy in a patient with aHUS

1 reference

12 December 2020

Eculizumab for the treatment of two recurrences of atypical hemolytic uremic syndrome in a kidney allograft

1 reference

12 December 2020

Identifiers

DOI

10.1038/KI.2014.423

1 reference

Dimensions Publication ID

26 July 2017

0 references

1 reference

26 July 2017

1 reference